AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

KORU Medical Systems, Inc. Director's Dealing 2021

Apr 14, 2021

33778_dirs_2021-04-14_9ef263c8-ef92-4520-b6ee-20fb9a753478.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REPRO MED SYSTEMS INC (KRMD)
CIK: 0000704440
Period of Report: 2021-04-12

Reporting Person: Tharby Linda M (President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-12	Common Stock	A	200000	—	Acquired	200000	Direct
2021-04-12	Common Stock	A	200000	—	Acquired	400000	Direct
2021-04-12	Common Stock	A	600000	—	Acquired	1000000	Direct

Footnotes

F1: Restricted stock awards vest in 25% increments annually beginning 3/15/22.

F2: Restricted stock awards vest based on a schedule of the Company's market capitalization prior to 3/15/27.

F3: Restricted stock awards vest based on a schedule of the Company's net sales growth targets for each of the fiscal years ended 12/31/22 through 12/31/25.